Bioprocess Sensors Patents: Who Leads, Where the Gaps Are 2026
Bioprocess Sensors and Soft Sensing Patents: Mapping the Filing Landscape
Filing peaked in 2020 at 88 records, then eased to 55 by 2024, a -23% move over 2021-2024 rather than a collapse. Annual filings rose to a peak of 88 in 2020, then declined to 55 by 2024 (-23% over 2021-2024). 2025 and 2026 figures are undercounted due to publication lag and should not be compared directly against complete years.
- 1VERTEX PHARMACEUTICALS INC101
- 2AMGEN INC53
- 3POTRERO MEDICAL52
- 4CILAG GMBH INTERNATIONAL38
- 5INTELLIDX INC32
See the full bioprocess sensors and soft sensing analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions about this landscape
Who holds the most bioprocess sensor patents?
The assignee ranking in this dataset covers 100 companies, with the leader holding 101 records against a fifth-place count of 32 and a tenth-place count of 23. That gap shows one company with a clear lead in filing volume, but the top 10 combined still only account for 36.9% of all 1,098 records, so the field is far from a two- or three-player market. Anyone assessing competitive risk should look at the full ranked list rather than assume the leader dominates the whole space.
Is patent filing in bioprocess sensing still growing?
Filings peaked at 88 in 2020 and fell to 55 by 2024, a -23% change over that three-year span using the last fully complete filing years. That is a cooling from a peak rather than a collapse, and figures for 2025 and 2026 are understated because publication typically lags filing by around 18 months. Treat any apparent recent drop with caution until later data years catch up.
What does the IPC class mix say about where the claims sit?
G01N (material analysis and testing) appears in 44.9% of the 1,098 records and A61B (diagnosis and surgery) in 28.8%, making physical and optical measurement the dominant claim surface. Software and AI-oriented classes such as G06N and G06F each sit near 4.5%, meaning the modelling side of soft sensing is present but thin relative to the hardware. A record can carry multiple classes, so these percentages do not sum to 100%.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Bioprocess Sensors and Soft Sensing covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.